Despite dampening factors, including a rigorous regulatory climate, dealmaking activity is poised for a surge. What boards should be thinking about as they plot strategy.
The anti-ESG backlash is in full swing, even as new regulation demands more disclosure and climate concerns threaten supply chains. How can boards find balance?